Point of Care Molecular Diagnostics Market Report

Name: Point of Care Molecular Diagnostics Market Size, Share, Growth and Industry Report
Creator: IMARC Group
License: https://www.imarcgroup.com/privacy-policy
Keywords: Point of Care Molecular Diagnostics Market Report

Point of Care Molecular Diagnostics Market Report by Product and Service (Assays and Kits, Instruments and Analyzers, Software and Services), Technology (Polymerase Chain Reaction (PCR), Hybridization, DNA sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), and Others), Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, and Others), End User (Physicians’ Offices, Hospitals and ICUs, Research Institutes, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A6271

Buy Now Discount
Offer

Market Overview:

The global point of care molecular diagnostics market size reached USD 4.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.7 Billion by 2033, exhibiting a growth rate (CAGR) of 8.78% during 2025-2033. The increasing incidence of infectious diseases paired with rapid development in healthcare facilities is significantly driving the market growth.

Report Attribute	Key Statistics
Base Year	2024
Forecast Years	2025-2033
Historical Years	2019-2024
Market Size in 2024	USD 4.0 Billion
Market Forecast in 2033	USD 8.7 Billion
Market Growth Rate 2025-2033	8.78%

Point-of-care (POC) molecular diagnostics refer to tests performed by physicians to diagnose and detect infectious diseases. It includes hematology, pregnancy, fertility, infectious diseases, urinalysis testing kits, and cardiometabolic and glucose monitoring devices. POC molecular diagnostics is widely used for identifying infectious agents, minimal residual disease, and gastrointestinal disorders, monitoring hemoglobin and fecal occult blood, and determining a patient's ability to metabolize a drug or drug class. These tests offer faster results, reduce complications associated with mistreatment, and improve infection control measures. As a result, POC molecular diagnostics finds extensive applications in hospitals, intensive care units (ICUs), research institutes, clinics, decentralized laboratories, and homecare facilities.

Point of Care Molecular Diagnostics Market

Point of Care Molecular Diagnostics Market Trends:

Increased Focus on Infectious Disease Diagnostics

The increasing prevalence of infectious diseases across the globe is creating a positive outlook for the market. The COVID-19 pandemic highlighted the importance of rapid testing for public health surveillance and outbreak management. POC molecular diagnostic test is a cost-effective solution widely used to manage infectious diseases, such as flu, tuberculosis, human immunodeficiency virus (HIV) infection, chlamydia, and hepatitis. It effectively supports in the early detection and containment of emerging infectious diseases, preventing their spread.

Product Enhancements

The adoption of miniaturization, nanotechnology, and microfluidics to develop low-cost, user-friendly, and highly sensitive molecular diagnostic tests is providing an impetus to the market growth. Moreover, the implementation of various government initiatives toward improving healthcare infrastructure and enhancing molecular diagnostic capabilities is positively influencing the market growth. Other factors, including rapid advancements in deoxyribonucleic acid (DNA) sequencing, rising awareness regarding advanced therapeutic and diagnostic tests, increasing geriatric population, and recent developments in cloud-connected POC diagnostic technologies, are anticipated to drive market growth.

Integration of Digital Technologies

Connecting point-of-care devices to the Internet of Things (IoT) enables real-time data collection, remote monitoring, and enhanced data management. Further, the integration of artificial intelligence technology to analyze test results, assist in diagnosis, and provide personalized treatment recommendations is creating new growth opportunities for the key market participants. In addition, the adoption of cloud-based platforms for facilitating data storage, sharing, and analysis, enabling collaboration between healthcare providers and researchers, is transforming the point of care molecular diagnostics market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global point of care molecular diagnostics market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on product and service, technology, application and end user.

Breakup by Product and Service:

Assays and Kits
Instruments and Analyzers
Software and Services

Breakup by Technology:

Polymerase Chain Reaction (PCR)
Hybridization
DNA sequencing
Microarray
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others

Breakup by Application:

Infectious Diseases
Oncology
Hematology
Prenatal Testing
Endocrinology
Others

Breakup by End User:

Physicians’ Offices
Hospitals and ICUs
Research Institutes
Others

Breakup by Region:

Point of Care Molecular Diagnostics Market By Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global point of care molecular diagnostics market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

Abbott Laboratories
Becton Dickinson and Company
Binx Health Inc.
Co-Diagnostics Inc.
F. Hoffmann-La Roche Ltd
Gene STAT Molecular Diagnostics LLC
Hemocue AB (Danaher Corporation)
Meridian Bioscience Inc.
Molbio Diagnostics Private Limited
Quidel Corporation
Siemens Healthcare GmbH (Siemens AG)
Thermo Fisher Scientific Inc.
Visby Medical Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Point of Care Molecular Diagnostics Market Recent Developments:

July 2024: Roche announced the acquisition of LumiraDx’s Point of Care technology for expanding access to diagnostic tests in primary care.
July 2024: Co-Diagnostics, Inc. announced that it will be hosting and presenting at the Association for Diagnostics & Laboratory Medicine (ADLM) annual meeting and expo in August 2024. It planned to exhibit the role of its new point-of-care and at-home Co-Dx PCR platform in limiting the global diagnostics gap for a diverse range of potential indications, including tuberculosis.

Report Scope:

Report Features	Details
Base Year of the Analysis	2024
Historical Period	2019-2024
Forecast Period	2025-2033
Units	Billion USD
Segment Coverage	Product and Service, Technology, Application, End User, Region
Region Covered	Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered	United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered	Abbott Laboratories, Becton Dickinson and Company, Binx Health Inc., Co-Diagnostics Inc., F. Hoffmann-La Roche Ltd, Gene STAT Molecular Diagnostics LLC, Hemocue AB (Danaher Corporation), Meridian Bioscience Inc., Molbio Diagnostics Private Limited, Quidel Corporation, Siemens Healthcare GmbH (Siemens AG), Thermo Fisher Scientific Inc., Visby Medical Inc.
Customization Scope	10% Free Customization
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

The global point of care molecular diagnostics market was valued at USD 4.0 Billion in 2024.

We expect the global point of care molecular diagnostics market to exhibit a CAGR of 8.78% during 2025-2033.

The escalating demand for point of care molecular diagnostics tests across hospitals, research institutes, clinics, etc., as they offer faster results and reduce complications associated with mistreatment, is primarily driving the global point of care molecular diagnostics market.

The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of point of care molecular diagnostics tests to effectively manage and control the spread of the coronavirus infection.

Based on the product and service, the global point of care molecular diagnostics market can be segmented into assays and kits, instruments and analyzers, and software and services. Currently, assays and kits hold the majority of the total market share.

Based on the technology, the global point of care molecular diagnostics market has been divided into Polymerase Chain Reaction (PCR), hybridization, DNA sequencing, microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), and others. Among these, Polymerase Chain Reaction (PCR) currently exhibits a clear dominance in the market.

Based on the application, the global point of care molecular diagnostics market can be categorized into infectious diseases, oncology, hematology, prenatal testing, endocrinology, and others. Currently, infectious diseases account for the largest market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global point of care molecular diagnostics market include Abbott Laboratories, Becton Dickinson and Company, Binx Health Inc., Co-Diagnostics Inc., F. Hoffmann-La Roche Ltd, Gene STAT Molecular Diagnostics LLC, Hemocue AB (Danaher Corporation), Meridian Bioscience Inc., Molbio Diagnostics Private Limited, Quidel Corporation, Siemens Healthcare GmbH (Siemens AG), Thermo Fisher Scientific Inc., and Visby Medical Inc.

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Purchase Options Discount
Offer

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.

Point of Care Molecular Diagnostics Market

Market Overview:

Point of Care Molecular Diagnostics Market Trends:

Key Market Segmentation:

Competitive Landscape:

Point of Care Molecular Diagnostics Market Recent Developments:

Report Scope:

Key Questions Answered in This Report

1. What was the size of the global point of care molecular diagnostics market in 2024?

2. What is the expected growth rate of the global point of care molecular diagnostics market during 2025-2033?

3. What are the key factors driving the global point of care molecular diagnostics market?

4. What has been the impact of COVID-19 on the global point of care molecular diagnostics market?

5. What is the breakup of the global point of care molecular diagnostics market based on the product and service?

6. What is the breakup of the global point of care molecular diagnostics market based on the technology?

7. What is the breakup of the global point of care molecular diagnostics market based on application?

8. What are the key regions in the global point of care molecular diagnostics market?

9. Who are the key players/companies in the global point of care molecular diagnostics market?